Hyloris Pharmaceuticals SA (EBR:HYL)

Hyloris Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 10, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	134	192	183	357	311	447
Market Cap Growth	-21.57%	4.59%	-48.71%	14.84%	-30.44%	82.10%
Enterprise Value	122	174	157	319	260	402
Last Close Price	4.80	6.84	6.54	12.75	11.60	17.30
PS Ratio	15.22	21.68	18.76	94.97	130.24	144.35
PB Ratio	5.08	7.23	5.70	9.14	5.77	9.30
P/TBV Ratio	6.47	9.21	6.03	10.13	5.97	9.67
EV/Sales Ratio	13.78	19.70	16.09	84.88	108.83	129.77
Debt / Equity Ratio	0.06	0.06	0.06	0.05	0.02	0.18
Net Debt / Equity Ratio	-0.48	-0.48	-0.69	-0.75	-0.80	-0.87
Net Debt / EBITDA Ratio	1.86	1.86	3.59	1.86	3.77	4.06
Net Debt / FCF Ratio	1.81	1.81	3.22	2.22	3.28	3.68
Asset Turnover	0.24	0.24	0.22	0.07	0.04	0.05
Quick Ratio	3.85	3.85	4.12	5.14	8.32	3.53
Current Ratio	3.89	3.89	4.15	5.22	8.63	3.60
Return on Equity (ROE)	-21.61%	-21.61%	-17.81%	-33.08%	-23.35%	-21.62%
Return on Assets (ROA)	-12.90%	-12.90%	-8.94%	-18.27%	-11.58%	-9.73%
Return on Capital Employed (ROCE)	-27.30%	-27.30%	-18.60%	-38.70%	-20.90%	-21.30%
Earnings Yield	-4.71%	-3.31%	-3.46%	-4.31%	-3.83%	-2.59%
FCF Yield	-5.21%	-3.65%	-3.79%	-3.67%	-4.22%	-2.54%
Buyback Yield / Dilution	1.65%	1.65%	-	-2.95%	-5.29%	-18.40%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.